BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

NCT06611436 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B
Hemophilia B, Moderately Severe or Severe

Interventions

DRUG: BE-101
DRUG: BE-101
DRUG: BE-101
DRUG: BE-101

Sponsor

Be Biopharma